We are live on ! Find out more
CLOV icon

Clover Health Investments

93 hedge funds and large institutions have $300M invested in Clover Health Investments in 2020 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 9393 (0)

0% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 66

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

2% less call options, than puts

Call options by funds: $72.9M | Put options by funds: $74.2M

39.64% less ownership

Funds ownership: 61.31%21.66% (-40%)

49% less capital invested

Capital invested by funds: $592M → $300M (-$292M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
93
Holders Change
Holders Change %
0%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
66
Increased
13
Reduced
13
Closed
66
Calls
$72.9M
Puts
$74.2M
Net Calls
-$1.25M
Net Calls Change
-$5.17M
Name Holding Trade Value Shares
Change
Change in
Stake
FC
26
FORA Capital
Florida
$2.23M +$1.48M +132,742 New
Wells Fargo
27
Wells Fargo
California
$1.86M +$442K +39,669 +56%
RJA
28
Raymond James & Associates
Florida
$1.8M +$885K +79,461 +286%
IC
29
Ikarian Capital
Texas
$1.68M +$1.11M +100,000 New
LA
30
Linden Advisors
New York
$1.66M -$67.9M -6,102,765 -98%
HF
31
HRT Financial
New York
$1.51M +$1M +89,949 New
UBS Group
32
UBS Group
Switzerland
$1.32M +$828K +74,367 +1,729%
PI
33
PEAK6 Investments
Illinois
$1.27M +$286K +25,661 +51%
MS
34
Maven Securities
Jersey
$1.17M -$334K -29,999 -30%
RFC
35
Regions Financial Corp
Alabama
$1.17M +$779K +70,000 New
MA
36
MYDA Advisors
New York
$1.07M +$713K +64,000 New
WCMNY
37
Westchester Capital Management (New York)
New York
$1.04M -$1.38M -123,750 -67%
SCA
38
Sassicaia Capital Advisers
New York
$1.01M +$674K +60,500 New
CG
39
Cutler Group
California
$958K +$636K +57,150 New
CL
40
CSS LLC
Illinois
$847K +$562K +50,523 New
Osaic Holdings
41
Osaic Holdings
Arizona
$831K +$274K +24,630 +99%
RJFSA
42
Raymond James Financial Services Advisors
Florida
$807K +$536K +48,117 New
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$595K +$390K +35,002 +7,000%
CAN
44
Cetera Advisor Networks
California
$588K +$391K +35,089 New
HT
45
HAP Trading
New York
$512K +$340K +30,529 New
AGM
46
Alpine Global Management
New York
$509K +$338K +30,360 New
Cambridge Investment Research Advisors
47
Cambridge Investment Research Advisors
Iowa
$434K -$728K -65,431 -72%
BSCM
48
Berry Street Capital Management
United Kingdom
$419K +$278K +25,000 New
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
$393K +$261K +23,416 New
PCM
50
Penserra Capital Management
California
$376K +$250K +22,441 New

CLOV Hedge Fund Activity: Q4 2020 in Review

93 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q4 2020, worth a combined $300M — down 49% from $592M a quarter earlier.

Fund positioning in CLOV was balanced in Q4 2020: 66 funds opened new positions, 66 closed out, 13 added to existing stakes and 13 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $23.9M. The largest seller was Linden Advisors, cutting an estimated $67.9M.

  • 93 institutional investors held Clover Health Investments (CLOV) as of Q4 2020, unchanged from Q3 2020.
  • Funds reported $300M of Clover Health Investments stock for Q4 2020, down 49% quarter-over-quarter.
  • 66 funds opened new Clover Health Investments positions in Q4 2020 and 66 closed out, a net change of 0 holders.
  • The largest Clover Health Investments buyer in Q4 2020 was Susquehanna International Group, an estimated $23.9M added.
  • The largest Clover Health Investments seller in Q4 2020 was Linden Advisors, an estimated $67.9M sold.

Based on aggregated 13F filings for Q4 2020.